Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Vaccine Status Drives Over One Million New Users to the NHS App
Over 1.3 million new people have registered to use the NHS App since the addition […]
Libtayo ® (Cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted […]
Pfizer Initiates Study Exploring Coadministration of 20vPnC Vaccine Candidate
Pfizer Inc. (NYSE: PFE) today announced that the first enrolled subjects have received their immunizations as […]
Moderna and Aldevron Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the […]
Verana Health Leads First-of-its-Kind Study Demonstrating Promise of Real-World Data in Ophthalmic Clinical Development
Verana Health, a healthcare technology and analytics innovator transforming multi-specialty clinical data into real-world evidence, […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
Royal Free Patient First to Receive Smartphone Connected Defibrillator
A 61-year-old year old man has become the first patient at the Royal Free London […]
Breakthrough 24-7 Blood Pressure Monitoring System Launched
Aktiia, the world’s first automated 24/7 blood pressure monitoring system which easily and comfortably collects […]
Drug Discovery Gets Jolt of AI via NVIDIA Collaborations with AstraZeneca, U of Florida Health
NVIDIA is collaborating with biopharmaceutical company AstraZeneca and the University of Florida’s academic health center, […]
Vinehealth and University of Surrey Awarded £1m Grant to Trial a Support App for Patients Undergoing Cancer Treatment
Vinehealth in partnership with University of Surrey have secured a grant from Innovate UK to undertake […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more